DABUR RESEARCH FOUNDATION.
31Patents
0Active
31Granted
35Portfolio score
Filing activity: Apr 16, 1997 → Aug 8, 2003
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6365191B1 | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof | Emerging Cross-Sectional Technologies | 39 | Expired |
| US6322817A | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof | Emerging Cross-Sectional Technologies | 36 | Expired |
| US6048847A | Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this | Chemistry; Metallurgy | 28 | Expired |
| US6136316A | Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection | Human Necessities | 20 | Expired |
| US7094755B2 | Vasoactive intestinal peptide analogs | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6403816B1 | Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis | Chemistry; Metallurgy | 12 | Expired |
| US6632832B1 | Anti-cancer activity of carvedilol and its isomers | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6670345B1 | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid | Chemistry; Metallurgy | 10 | Expired |
| US6395771B1 | Paclitaxel derivatives for the treatment of cancer | Human Necessities | 10 | Expired |
| US6613793B2 | Anticancer activity of imino acid conjugates or methylglyoxal | Human Necessities | 9 | Expired |
| US6455077B2 | Herbal composition and method of manufacturing such composition for the management of gynecological disorders | Human Necessities | 7 | Expired |
| US6124482A | Process for isolation of 10-deacetyl baccatin-III | Chemistry; Metallurgy | 7 | Expired |
| US6264998A | Extracting betulinic acid from Ziziphus jujuba | Human Necessities | 6 | Expired |
| US6489297B1 | Vasoactive intestinal peptide analogs | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6596755B2 | Oral formulation of methylglyoxal and its imino acid conjugates for human use | Human Necessities | 5 | Expired |
| US6828304B1 | Peptides for treatment of cancer | Human Necessities | 5 | Expired |
| US6608174B1 | Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy | Human Necessities | 5 | Expired |
| US6492330B1 | Antiangiogenic drugs | Human Necessities | 5 | Expired |
| US6228850A | Antiangiogenic activity of betulinic acid and its derivatives | Chemistry; Metallurgy | 5 | Expired |
| US6316414A | Somatostatin analogs for the treatment of cancer | Human Necessities | 4 | Expired |
| US7060678B2 | Peptides comprising furanoid sugar amino acids for the treatment of cancer | Human Necessities | 4 | Expired |
| US6214814A | Use of betulinic acid derivatives for inhibiting cancer growth | Chemistry; Metallurgy | 3 | Expired |
| US6596692B1 | Substance P analogs for the treatment of cancer | Human Necessities | 2 | Expired |
| US7173006B2 | Drug comprising synthetic peptide analogs for the treatment of cancer | Human Necessities | 2 | Expired |
| US6002024A | Process for the isolation of 14.beta.-hydroxy-10-deacetyl baccatin-III | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.